Avandia Linked to Increased Risk of Heart Attack
The Food and Drug Administration (FDA) issued a safety alert on diabetes drug Avandia after studies found a potentially significant increased rate of heart-related deaths among patients taking the diabetes drug.
The New England Journal of Medicine reports studies showing up to a 43% increase in heart attacks and other heart problems in people using Avandia.
Avandia was approved in 1999 for treatment of type 2 diabetes. Since the drug was approved, FDA has monitored heart-related side effects. Some of these side effects included edema and congestive heart failure. In 2006, the most recent labeling change for Avandia for the first time added a new warning about a potential increase in heart attacks and heart-related chest pain in some individuals using Avandia.
Patients who are taking Avandia, particularly those who have underlying heart conditions, should contact their doctor about this new information to determine the proper course of treatment.
Individuals who have been injured after taking Avandia can contact attorney Brian Goldstein. Goldstein is an attorney who is a former Board Certified Surgeon and heads up the mass tort department at The Barnes Firm.
About The Barnes Firm:
The Barnes Firm presently represents thousands of clients who have been injured after ingesting Vioxx. In addition to Vioxx, the firm has also successfully represented clients harmed by other prescription drugs including Baycol and Fen Phen.
For more information, visit The Barnes Firm website at www.TheBarnesFirm.com or contact attorney Brian Goldstein at 1-800-483-2050.
- Contact Information
- Daryl Ciambella
- Chief Operating Officer
- The Barnes Firm
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.